Strategic buyers Target large healthcare networks and hospitals that value low-temperature sterilization for heat-sensitive devices, leveraging TSO3's partnership history with Mount Sinai and its halting growth in high-growth sterilization markets to position for enterprise contracts.

Acquisition legacy Leverage past acquisition by Stryker as a case study to engage mid-market medical device manufacturers seeking proven M&A exits or strategic endorsements, highlighting stability and growth trajectory in the low-temperature sterilization niche.

Global reach Capitalize on dual Canada-US presence to pursue cross-border sales of sterilization technology to North American medical device manufacturers, emphasizing regional support, regulatory familiarity, and proximity to major centers of healthcare innovation.

R&D partnerships Exploit a history of ongoing R&D leadership and academic collaborations to offer co-development or joint-venture opportunities with device makers developing heat-sensitive equipment, aligning product roadmaps with customer needs.

Financial opportunity Position toward mid-sized healthcare suppliers with revenue in the tens of millions and growing, presenting TSO3’s sterilization platform as a differentiator in a high-growth segment to expand service contracts, installation pipelines, and long-term maintenance deals.